Cargando…
Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses
Predictive biomarkers are important for selecting appropriate patients for particular treatments. Comprehensive genomic, transcriptomic, and pharmacological data provide clues for understanding relationships between biomarkers and drugs. However, it is still difficult to mine biologically meaningful...
Autores principales: | Fujita, Naoya, Mizuarai, Shinji, Murakami, Katsuhiko, Nakai, Kenta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021419/ https://www.ncbi.nlm.nih.gov/pubmed/29950679 http://dx.doi.org/10.1038/s41598-018-28066-w |
Ejemplares similares
-
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
por: Itadani, Hiraku, et al.
Publicado: (2008) -
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
por: Mizuarai, Shinji, et al.
Publicado: (2009) -
Biomarker Gene Signature Discovery Integrating Network Knowledge
por: Cun, Yupeng, et al.
Publicado: (2012) -
Stable feature selection based on the ensemble L(1)-norm support vector machine for biomarker discovery
por: Moon, Myungjin, et al.
Publicado: (2016) -
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
por: Mizuarai, Shinji, et al.
Publicado: (2009)